UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS
暂无分享,去创建一个
[1] L. Curtis,et al. Unit Costs of Health and Social Care 2016 , 2015 .
[2] A. Morris. A European Survey , 2013 .
[3] F. Cots,et al. Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals? , 2013, BMJ.
[4] S. Tan,et al. Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg , 2012, Tijdschrift voor gezondheidswetenschappen.
[5] W. B. van den Hout,et al. The value of productivity: human-capital versus friction-cost method , 2009, Annals of the rheumatic diseases.
[6] Siok Swan Tan. Microcosting in economic evaluations: Issues of accuracy, feasibility, consistency and generalisability , 2009 .
[7] F. Rutten,et al. Comparing methodologies for the cost estimation of hospital services , 2009, The European Journal of Health Economics.
[8] N. J. Exel,et al. Unrelated Medical Costs in Life-Years Gained , 2008, PharmacoEconomics.
[9] J. Wasem,et al. Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation – ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG). , 2005 .
[10] M. Postma,et al. Need for differential discounting of costs and health effects in cost effectiveness analyses , 2005, BMJ : British Medical Journal.
[11] J Raftery,et al. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. , 2005, Health technology assessment.
[12] J Raftery,et al. Potential use of routine databases in health technology assessment. , 2005, Health technology assessment.
[13] Risto Lehtonen,et al. Multilevel Statistical Models , 2005 .
[14] A. Ludbrook,et al. Collecting unit cost data in multicentre studies , 2005, The European Journal of Health Economics.
[15] B. Ferguson,et al. NHS database of reference costs is severely flawed , 2001, BMJ : British Medical Journal.
[16] J Hjelmgren,et al. Health economic guidelines--similarities, differences and some implications. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[17] J. Graf von der Schulenburg,et al. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. , 2000, Health policy.
[18] A. Mcguire,et al. Centre-specific or average unit costs in multi-centre studies? Some theory and simulation. , 2000, Health economics.
[19] M J Buxton,et al. Assessing the costs of healthcare technologies in clinical trials. , 1999, Health technology assessment.
[20] P. Barnett,et al. Cost analysis in the Department of Veterans Affairs: consensus and future directions. , 1999, Medical care.
[21] M. Koopmanschap,et al. A Practical Guide for Calculating Indirect Costs of Disease , 1996, PharmacoEconomics.
[22] A. Culyer,et al. Discounting and decision making in the economic evaluation of health-care technologies. , 2011, Health economics.
[23] P. van Baal,et al. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? , 2008, PharmacoEconomics.
[24] J. Wasem,et al. [Empirical standard costs for health economic evaluation in Germany -- a proposal by the working group methods in health economic evaluation]. , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).
[25] Richard Willke,et al. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[26] A. Ludbrook,et al. Collecting unit cost data in multicentre studies. Creating comparable methods. , 2005, The European journal of health economics : HEPAC : health economics in prevention and care.
[27] Risto Lethonen. Multilevel Statistical Models (3rd ed.) , 2005 .
[28] D. Quinton,et al. Unit Costs of Health and Social Care 2004 , 2004 .
[29] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[30] Jan B Oostenbrink,et al. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. , 2002, PharmacoEconomics.